NuCana (NCNA) Income towards Parent Company (2017 - 2025)

NuCana (NCNA) reported Income towards Parent Company of -$3.7 million for Q4 2025, down 339.46% on a YoY basis from $1.5 million in Q4 2024, and down 871.39% sequentially from -$379170.8 in Q3 2025.

NuCana (NCNA) Income towards Parent Company (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Income towards Parent Company data on file, last reported at -$3.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 339.46% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at -$39.3 million (down 62.57% YoY), and the FY2025 full-year result was -$41.8 million, down 72.06% from the prior year.
  • Income towards Parent Company slipped to -$3.7 million in Q4 2025, from -$379170.8 in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $12.7 million in Q2 2021 to a low of -$32.2 million in Q2 2025.
  • A 5-year average of -$7.9 million and a median of -$8.6 million in 2023 frame the typical range for Income towards Parent Company.
  • Peak annual rise in Income towards Parent Company reached 268.77% in 2021, while the deepest fall reached 364.75% in 2021.
  • Tracing NCNA's Income towards Parent Company over 5 years: stood at -$18.4 million in 2021, then rose by 3.07% to -$17.8 million in 2022, then surged by 46.71% to -$9.5 million in 2023, then jumped by 91.18% to -$838126.7 in 2024, then slumped by 339.46% to -$3.7 million in 2025.
  • Business Quant data shows NCNA's Income towards Parent Company at -$3.7 million in Q4 2025, -$379170.8 in Q3 2025, and -$32.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 NuCana 14.38 Bn 14.34 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.68 Mn
Sep 30, 2025 -379,170.76
Jun 30, 2025 -32.17 Mn
Mar 31, 2025 -3.11 Mn
Dec 31, 2024 -838,126.70
Sep 30, 2024 -5.86 Mn
Jun 30, 2024 -8.83 Mn
Mar 31, 2024 -8.67 Mn
Dec 31, 2023 -9.50 Mn
Sep 30, 2023 -8.48 Mn
Jun 30, 2023 -6.77 Mn
Mar 31, 2023 -9.56 Mn
Dec 31, 2022 -17.83 Mn
Sep 30, 2022 -5.34 Mn
Jun 30, 2022 4.90 Mn
Mar 31, 2022 -11.28 Mn
Dec 31, 2021 -18.39 Mn
Sep 30, 2021 -11.09 Mn
Jun 30, 2021 12.70 Mn
Mar 31, 2021 -13.46 Mn